in your honest opinion and based on the research do you think this has the possibility to get to $50? would that be within the next year year or further out?
or is 50 more of a pipe dream with 20 being closer to reality?
I honestly believe it will reach $50 in the next year. Back when we got approval in Europe and anticipation of a partnership it went to like $52. With U.S. approval it will do that easily because of these reasons.
CRMD:
-just joined Russell 2000 index
-low float
-superb P3 trial and P value
-72% better than standard of care
-no safety concerns
-enough cash until Q3 2020
-fast track,QIDP and unmet need
-10.5 years exclusivity
-FDA news any day
-partnership down the road
quoted from Yahoo finance
If this does get approved, it good to understand this is not just a regular drug, it will be the standard of care and is an unmet medical need. Analyst have set a price target of $27 on the high end and $20 mid range. But this is where the price will ultimately settle this DOES NOT account for parabolic spikes. And with a low float it will go parabolic with good news. Were up about $2 in the past week alone just off the Russell addition